IndraLab

Statements


| 2

reach
"USP44 inhibit tumor cells progression and regulated gemcitabine resistance in PDAC."

reach
"Ye et al. showed that an increased METTL3-mediated m6A modification of lncRNA DBH-AS1 can competitively bind to miR-3163 and upregulate ubiquitin-specific peptidase 44 (USP44), thereby inhibiting PC growth and gemcitabine resistance [146]."